Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

Lymphocyte Subpopulations and Expression of Immune Checkpoint Receptors PD-1 and Tim-3 in Patients with Chronic Myeloid Leukemia in a Discontinuation Trial

Fernanda S Seguro, MD, Felipe VR Maciel, MD, Guilherme O Lopes, Luciana Nardinelli, M.Sc, Vanderson Rocha, MD PhD, Israel Bendit, MD PhD

Blood (2019) 134 (Supplement_1): 1651.

https://doi.org/10.1182/blood-2019-125989

Published: 2019

Journal Articles

Correction of Iron Deficiency in Hospitalized Heart Failure Patients Does Not Improve Patient Outcomes

Ronak Mistry, DO, Andrew Kohut, MD MPH, Patricia Locantore-Ford, MD

Blood (2019) 134 (Supplement_1): 4812.

https://doi.org/10.1182/blood-2019-123568

Published: 2019

Journal Articles

A Prospective, Open-Label, Multicenter, Phase 2 Trial to Evaluate the Safety and Efficacy of the Combination of Tirabrutinib (ONO/GS-4059) and Idelalisib with and without Obinutuzumab in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)

Nadine Kutsch, MD, Christian Pallasch, Thomas Decker, Holger Hebart, Kai Uwe Chow, Ullrich Graeven, Jens Kisro, Alexander Kroeber, Eugen Tausch, Clemens-Martin Wendtner, Michael J. Eckart, Stephan Stilgenbauer, Xi Huang, Juliane M. Jürgensmeier, Pankaj Bhargava, Michael Hallek, Barbara F. Eichhorst, MD

Blood (2019) 134 (Supplement_1): 3047.

https://doi.org/10.1182/blood-2019-131025

Published: 2019

Journal Articles

Initial Safety and Efficacy of Dose-Escalating HDACs Inhibitor Chidamide with VRD (Chi-VRD) Treatment for Newly-Diagnosed High-Risk Transplant Eligible Multiple Myeloma Patients

Jingjing Shang, Weiqin Yao, Lingzhi Yan, Xiaolan Shi, Ruju Wang, Shuang Yan, Yong Liu, Depei Wu, MD PhD, Fu Cheng Cheng, MD PhD

Blood (2019) 134 (Supplement_1): 1855.

https://doi.org/10.1182/blood-2019-129434

Published: 2019

Journal Articles

Burden of Hospital Readmissions for Venous Thromboembolism Among Patients with Cancer

Alpesh J. Amin, MD MBA, Steven Deitelzweig, MD, Jay Lin, PhD MBA, Melissa Lingohr-Smith, PhD, Brandy Menges, PhD, W. Richey Neuman, MD MPH

Blood (2018) 132 (Supplement 1): 365.

https://doi.org/10.1182/blood-2018-99-112288

Published: 2018

Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation Using Fludarabine/Melphalan and Low-Dose Total Body Irradiation: A Single Center Analysis

Tatsuji Mino, Yuta Katayama, MD PhD, Tatsuya Terasaki, MD, Yu Kochi, MD, Fumiaki Jinnouchi, MD, Takeshi Okatani, MD, Ryota Imanaka, MD, Kohei Kyo, MD, Mitsuhiro Itagaki, MD, Shinya Katsutani, MD PhD, Tsuyoshi Muta, MD, Koji Iwato, MD PhD, Hideki Asaoku, MD

Blood (2018) 132 (Supplement 1): 2095.

https://doi.org/10.1182/blood-2018-99-113461

Published: 2018

Journal Articles

Efficacy and Tolerability of Daratumumab in Heavily Pretreated AL Amyloidosis: A Systematic Review

Muhammad Aadil Rahman, MD, Ali Younas Khan, MD, Awais Ijaz, MD, Muhammad Junaid Tariq, MD, Muhammad Usman, MD, Muhammad Jahanzeb Khalil, MD, Muhammad Asad Fraz, MD, Faiza Jamil, MD, Abdul Rafae, MD, Mustafa Nadeem Malik, MD, Insija Ilyas Selene, MBBS, Jemin Aby Jose, MD, Ahmad Safdar, BS, Ali McBride, PharmD,MS, Faiz Anwer, MD

Blood (2018) 132 (Supplement 1): 2025.

https://doi.org/10.1182/blood-2018-99-115214

Published: 2018

Journal Articles

Overall Survival of Relapsed/Refractory Multiple Myeloma Patients Treated with Carfilzomib and Dexamethasone Vs Bortezomib and Dexamethasone: Results from the Phase 3 Endeavor Study According to Age Subgroup

Ruben Niesvizky, MD, Heinz Ludwig, MD, Andrew Spencer, MD, Hartmut Goldschmidt, MD, Tomas Pika, Maria-Victoria Mateos, Meletios A. Dimopoulos, Lifen Zhou, Amy S. Kimball, Thierry Facon, MD

Blood (2017) 130 (Supplement 1): 1885.

https://doi.org/10.1182/blood.V130.Suppl_1.1885.1885

Published: 2017

Journal Articles

Long-Term Outcome after Haploidentical Hematopoietic Cell Transplantation Utilizing CD34+ Selected/CD3CD19+ Depleted or Tcrαβ+/CD19+ Depleted Grafts in Pediatric Patients with Hemoglobinopathies

Javid Gaziev, Antonella Isgrò, MD, Pietro Sodani, MD, Katia Paciaroni, MD, Gioia De Angelis, MD, Marco Marziali, MD, Michela Ribersani, MD, Cecilia Alfieri, MD, Marco Andreani, PhD, Tiziana Gallucci, PhD, Guido Lucarelli, MD

Blood (2017) 130 (Supplement 1): 663.

https://doi.org/10.1182/blood.V130.Suppl_1.663.663

Published: 2017

Journal Articles

Adrenal Insufficiency: An Emerging Challenge in Thalassemia?

Marta Mancarella, MD, Diletta Maira, MD, Valeria Ferla, Marco Capecchi, MD, Irene Motta, MD, Elena Cassinerio, MD, Alessia Marcon, MD, Marina Baldini, MD, Maria Domenica Cappellini, MD

Blood (2016) 128 (22): 4830.

https://doi.org/10.1182/blood.V128.22.4830.4830

Published: 2016

Journal Articles

Cardiac Complications in Thrombotic Thrombocytopenic Purpura: Data from Nationwide Inpatient Sample

Ranjan Pathak, MD, Madan Raj Aryal, MD, Smith Giri, MD, Paras Karmacharya, MD, Anthony A Donato, MDMHPE

Blood (2014) 124 (21): 2793.

https://doi.org/10.1182/blood.V124.21.2793.2793

Published: 2014

Journal Articles

The Measure of Plasma Concentrations Is Crucial in Managing Dabigatran Treatment in Non-Valvular Atrial Fibrillation

Diana Iosub, MD, Rosa Trotti, MD, Franco Piovella, MD

Blood (2014) 124 (21): 5088.

https://doi.org/10.1182/blood.V124.21.5088.5088

Published: 2014

Journal Articles

Final Analysis of the RO-CHOP Phase Ib/II Study: Romidepsin in Association with CHOP in Patients with Peripheral T-Cell Lymphoma (PTCL)

Jehan Dupuis, MD, Franck Morschhauser, MD PhD, Herve Ghesquieres, MD PhD, Herve Tilly, MD, Olivier Casasnovas, MD, Sandy Amorim, MD, Vincent Ribrag, MD, Bertrand Coiffier, MD PhD

Blood (2014) 124 (21): 504.

https://doi.org/10.1182/blood.V124.21.504.504

Published: 2014

Journal Articles

Clinical Research on Hematological Malignancies Complicated with dic-a Single Center Report in China

Qing Wei, Ting Niu, MD PhD

Blood (2014) 124 (21): 5062.

https://doi.org/10.1182/blood.V124.21.5062.5062

Published: 2014

Journal Articles

“CARDIOVASCULAR and Metabolic Complications in Patients with Hematological Malignancies Undergoing Allogeneic Hematopoietic STEM CELL Transplantation (HSCT)”

Eleonora Arboscello, MD, Vera Sicbaldi, MD, Federica Galaverna, MD, Fabio Guolo, MD, Paolo Spallarossa, MD, Martina Giovannini, MD, Danilo Baccino, MD, Maria Teresa Van Lint, MD, Matteo Sarocchi, MD, Andrea Bellodi, MD, Lisette Del Corso, MD, Serena Favorini, MD, Elisa Molinari, MD, Jacopo Agnelli Giacchello, MD, Chiara Salvetti, MD, Riccardo Ghio, PhD MD, Andrea Bacigalupo, MD

Blood (2014) 124 (21): 1149.

https://doi.org/10.1182/blood.V124.21.1149.1149

Published: 2014

Journal Articles

Clinical Predictors of Prophylaxis Use Prior to the Onset of Acute Venous Thromboembolism in Hospitalized Patients: Swiss Venous ThromboEmbolism Registry (SWIVTER)

Nils Kucher, MD, David Spirk, MD, Christoph Kalka, MD, Lucia Mazzolai, MD, Daniel Nobel, MD, Martin Banyai, MD, Beat Frauchiger, MD, Henri Bounameaux, MD

Blood (2008) 112 (11): 3019.

https://doi.org/10.1182/blood.V112.11.3019.3019

Published: 2008

Journal Articles

Left Ventricular Cardiac Function during the Course of a One Year Multicenter Trial of the Safety and Efficacy with ICL670 5–40mg/kg/day and Deferoxamine 20–60 mg/kg/day in Beta-Thalassemia Patients with Transfusional Hemosideosis.

Dorothy A. Kleinert, NP, MPH, Erica Jones, MD, Cristina P. Sison, PhD, Peter Marks, MD, PhD, Patricia J. Giardina, MD

Blood (2005) 106 (11): 3853.

https://doi.org/10.1182/blood.V106.11.3853.3853

Published: 2005

Journal Articles

Late Increase of Peripheral CD34+ Cells Number during Acute Liver Failure Recovery.

Bernard Drénou, Anne Corlu, Yoann Desille, Christèle Sicot, Olivier Fardel, Laurence Amiot, Richard Lorho, Christophe Camus, Anne Guillygomarc’h, Karim Boudjema, Dominique Guyader

Blood (2005) 106 (11): 4223.

https://doi.org/10.1182/blood.V106.11.4223.4223

Published: 2005

Journal Articles

Reduced-Intensity Conditioning Regimen without Total Body Irradiation undergoing Umbilical Cord Blood Transplantation (non-TBI-RI-UCBT) Induces Successful Engraftment in Adult Patients with Advanced Hematological Malignancies.

Ko Miyamoto, Shigesaburo Miyakoshi, Aki Kyo, Koichiro Yuji, Eiji Kusumi, Fumiaki Sano, Shuichi Taniguchi, Haruhisa Nagosi

Blood (2004) 104 (11): 5177.

https://doi.org/10.1182/blood.V104.11.5177.5177

Published: 2004

Journal Articles

Identification of Medical Patients Who Should Receive Venous Thromboembolism Prophylaxis.

Alexander T. Cohen, Raza Alikhan, Juan I. Arcelus, Jean-François Bergmann, Sylvia Haas, Geno J. Merli, Alex C. Spyropoulos, Victor F. Tapson, Alexander G.G. Turpie

Blood (2004) 104 (11): 1786.

https://doi.org/10.1182/blood.V104.11.1786.1786

Published: 2004

NARROW

Lymphocyte Subpopulations and Expression of Immune Checkpoint Receptors PD-1 and Tim-3 in Patients with Chronic Myeloid Leukemia in a Discontinuation Trial

Correction of Iron Deficiency in Hospitalized Heart Failure Patients Does Not Improve Patient Outcomes

A Prospective, Open-Label, Multicenter, Phase 2 Trial to Evaluate the Safety and Efficacy of the Combination of Tirabrutinib (ONO/GS-4059) and Idelalisib with and without Obinutuzumab in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)

Initial Safety and Efficacy of Dose-Escalating HDACs Inhibitor Chidamide with VRD (Chi-VRD) Treatment for Newly-Diagnosed High-Risk Transplant Eligible Multiple Myeloma Patients

Burden of Hospital Readmissions for Venous Thromboembolism Among Patients with Cancer

Allogeneic Hematopoietic Stem Cell Transplantation Using Fludarabine/Melphalan and Low-Dose Total Body Irradiation: A Single Center Analysis

Efficacy and Tolerability of Daratumumab in Heavily Pretreated AL Amyloidosis: A Systematic Review

Overall Survival of Relapsed/Refractory Multiple Myeloma Patients Treated with Carfilzomib and Dexamethasone Vs Bortezomib and Dexamethasone: Results from the Phase 3 Endeavor Study According to Age Subgroup

Long-Term Outcome after Haploidentical Hematopoietic Cell Transplantation Utilizing CD34+ Selected/CD3CD19+ Depleted or Tcrαβ+/CD19+ Depleted Grafts in Pediatric Patients with Hemoglobinopathies

Adrenal Insufficiency: An Emerging Challenge in Thalassemia?

Cardiac Complications in Thrombotic Thrombocytopenic Purpura: Data from Nationwide Inpatient Sample

The Measure of Plasma Concentrations Is Crucial in Managing Dabigatran Treatment in Non-Valvular Atrial Fibrillation

Final Analysis of the RO-CHOP Phase Ib/II Study: Romidepsin in Association with CHOP in Patients with Peripheral T-Cell Lymphoma (PTCL)

Clinical Research on Hematological Malignancies Complicated with dic-a Single Center Report in China

“CARDIOVASCULAR and Metabolic Complications in Patients with Hematological Malignancies Undergoing Allogeneic Hematopoietic STEM CELL Transplantation (HSCT)”

Clinical Predictors of Prophylaxis Use Prior to the Onset of Acute Venous Thromboembolism in Hospitalized Patients: Swiss Venous ThromboEmbolism Registry (SWIVTER)

Left Ventricular Cardiac Function during the Course of a One Year Multicenter Trial of the Safety and Efficacy with ICL670 5–40mg/kg/day and Deferoxamine 20–60 mg/kg/day in Beta-Thalassemia Patients with Transfusional Hemosideosis.

Late Increase of Peripheral CD34+ Cells Number during Acute Liver Failure Recovery.

Reduced-Intensity Conditioning Regimen without Total Body Irradiation undergoing Umbilical Cord Blood Transplantation (non-TBI-RI-UCBT) Induces Successful Engraftment in Adult Patients with Advanced Hematological Malignancies.

Identification of Medical Patients Who Should Receive Venous Thromboembolism Prophylaxis.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only